Deprecated: Required parameter $field follows optional parameter $value in /customers/6/e/3/senatormedical.se/httpd.www/wp-content/plugins/stm-gdpr-compliance/includes/plugins/GravityForms.php on line 142
Warning: Cannot modify header information - headers already sent by (output started at /customers/6/e/3/senatormedical.se/httpd.www/wp-content/plugins/stm-gdpr-compliance/includes/plugins/GravityForms.php:142) in /customers/6/e/3/senatormedical.se/httpd.www/wp-includes/feed-rss2.php on line 8
breast cancer surgery – Senator Medical AB
https://www.senatormedical.se
Strategic partner in Healthcare businessWed, 11 Dec 2019 08:55:11 +0000en-US
hourly
1 https://wordpress.org/?v=6.5.2https://www.senatormedical.se/wp-content/uploads/2018/11/cropped-Senator-Logo.jpgbreast cancer surgery – Senator Medical AB
https://www.senatormedical.se
323260550935Focus shift: Breast Cancer from treatment to prevention
https://www.senatormedical.se/breast-cancer-prevention-comes-to-focus-instead-of-treatment-oncology-article-senator-medical-ab-stockholm-sweden/
https://www.senatormedical.se/breast-cancer-prevention-comes-to-focus-instead-of-treatment-oncology-article-senator-medical-ab-stockholm-sweden/#respondWed, 11 Dec 2019 08:55:00 +0000https://www.senatormedical.se/?p=2018If protective measures were widely adopted, they could significantly reduce women’s chances of ever getting breast cancer.
Efforts to reduce deaths from breast cancer in women have long focused on early detection and post-surgical treatment with drugs, radiation or both to help keep the disease at bay. And both of these approaches, used alone or together, have resulted in a dramatic reduction in breast cancer mortality in recent decades.
The average five-year survival rate is now 90 percent, and even higher — 99 percent — if the cancer is confined to the breast, or 85 percent if it has spread to regional lymph nodes.
Yet, even though a steadily growing percentage of women now survive breast cancer, the disease still frightens many women and their loved ones. It affects one woman in eight and remains their second leading cancer killer, facts that suggest at least equal time should be given to what could be an even more effective strategy:
Prevention
Long-term studies involving tens of thousands of women have highlighted many protective measures that, if widely adopted, could significantly reduce women’s chances of ever getting breast cancer. Even the techniques now used to screen for possible breast cancer can help identify those women who might be singled out for special protective measures.
]]>https://www.senatormedical.se/breast-cancer-prevention-comes-to-focus-instead-of-treatment-oncology-article-senator-medical-ab-stockholm-sweden/feed/02018Importance of Body image for women (Breast Cancer Article)
https://www.senatormedical.se/importance-of-body-image-for-women-breast-cancer-article-dignicap-senator-medical-ab/
https://www.senatormedical.se/importance-of-body-image-for-women-breast-cancer-article-dignicap-senator-medical-ab/#respondMon, 19 Aug 2019 12:23:05 +0000https://www.senatormedical.se/?p=1923Body image in women with breast cancer using a scalp cooling system to reduce chemotherapy induced hair-loss
Background: Most women consider hair to be an important part of body image. Alopecia is an emotionally traumatic side effect for breast cancer patients undergoing adjuvant chemotherapy. The DigniCap Scalp Cooling System is the first scalp cooling system cleared by the US Food and Drug Administration to reduce the likelihood of chemotherapy induced alopecia.
Methods: Quality of Life (QOL) data were collected as part of a prospective clinical trial evaluating the clinical performance of scalp cooling in women with early stage BC receiving adjuvant chemotherapy.
The study’s primary endpoint was hair loss as evaluated by patient self-assessment. Treatment success was defined as ≤ 50% hair loss. QOL was evaluated by the EORTC-QLQ-BR23 (BR23) administered at baseline, last chemotherapy cycle, and one month later. For BR23, 4 response categories were collapsed to 2 categories (Not at all/A little bit and Quite a bit/Very much) for analysis. QOL was compared between those with success vs. failure of scalp cooling.
Results: 101 patients were evaluable for the primary endpoint: Success was seen in 67 (66.3%) pts. QOL at study entry was comparable between pts with scalp cooling success or failure for each item in the BR23 questionnaire. Results reported as percentages of patients in each group who answered either quite a bit or very much to body image-related questions on the BR23 questionnaire are displayed in Table 1.
Conclusions: Women with breast cancer using scalp cooling during chemotherapy who had hair preservation experienced improved quality of life, according to self-assessment of body image, compared to women who had significant hair loss.
]]>https://www.senatormedical.se/importance-of-body-image-for-women-breast-cancer-article-dignicap-senator-medical-ab/feed/01923Role and duties of a surgical oncologist
https://www.senatormedical.se/know-more-about-your-cancer-doctors-who-is-surgical-oncologist-doctor-and-what-he-actually-does/
https://www.senatormedical.se/know-more-about-your-cancer-doctors-who-is-surgical-oncologist-doctor-and-what-he-actually-does/#respondFri, 09 Aug 2019 10:16:29 +0000https://www.senatormedical.se/?p=1774History of Surgical Oncology
Surgical oncology, as a specialised method of surgery for cancerous tumours, has evolved since the last three decades. Surgery is usually considered to be the most effective method of treatment of cancer. Ephraim McDowell undertook the first reported cancer surgery for ovarian tumour in 1809.
Who is a Surgical Oncologist?
Surgical oncologists specialise in the treatment of malignant neoplastic disease, with in-depth knowledge and expertise to perform the standard and advanced procedures as considered necessary for each patient. An accomplished surgical oncologist not only possesses the ability to diagnose tumours but has adequate knowledge in haematology, pathology, medical oncology and radiation oncology. Surgical oncologists, when considered necessary, refer patients to radio therapists for tests, and ensure appropriate multimodality care. This, in turn, aids in undertaking the accurate line of treatment. Over the past 30 years, Dr. Amish Dalal has successfully diagnosed and treated patients with cancer.
Multidisciplinary Management of Cancer
As discussed above, surgical oncologists referring patients to radio oncologists denote the multidisciplinary management of the treatment. Solid malignancies can be treated successfully simply through therapy alone, when detected during the early stage. However, in addition to standard therapy treatment, surgeries are indicated in advanced stages. This supports the argument that surgery is usually opted as an effective method in the treatment of cancer. Dr Amish V Dalal, a Surgical Oncologist, is renowned for his expertise in conducting cancer surgeries.
An Overview of the Role of a Surgical Oncologist
The role of a surgical oncologist primarily spans over four areas:
Exploring the scope of effective treatment solely through therapy, especially in early stages, which may avoid the need of a resection (removal of a tumour through surgery)
Excision of malignant tumours
Removal of malignant lymph nodes at the time of surgery
Treating any cases of recurrence of the disease
A study of the complete history of a patient and physical examination during consultation helps the surgical oncologist to assess the medical condition of the patient and decide upon the line of treatment, that is, whether it is treatable through therapy alone, or it warrants resection. If managed through surgery, a combination of post-surgical treatment including radiotherapy and chemotherapy is generally followed.
An acclaimed surgical oncologist is adept with removing cancer tumours and a portion of surrounding tissue, which may not look infected macroscopically but carries the risk of being malignant, which may be detected microscopically. This procedure usually helps in preventing the disease from spreading to other parts of the body and recurring in the future. In the case of borderline resection, the oncologist conducts a surgery, referred to as ‘Debulking’, to remove as much tumour as is considered possible and follow-up with post-surgery therapy to relieve pain. Amish Dalal, a renowned Oncologist, is proficient with conducting gynaecological oncological surgeries, after analysing the nature, location and stage of tumours.
Methods of Surgery
The method of surgery followed by the surgical oncologist depends on the location and stage of the disease, as well as other factors including health condition and fitness of the patient. Doctor Amish Dalal has the necessary expertise in the following methods of cancer surgery:
Open Surgery
Laparoscopy, depending on the patient’s medical condition and financial resources
Robotic Surgery
Doctor Amish Dalal, with his knowledge in his field of specialisation and along with the state-of-the-art surgical equipments, is able to provide world-class management of the disease. Dr. Amish Vasant Dalalalso conducts Robotic Surgery – one of the most advanced surgical methods in the field of medical science. The surgery provides the surgeon the advantage of 10x magnification along with a 3D view while operating. This method of surgery not only reduces pain considerably but also ensures speedy recovery as compared to Open Surgery.
Role Of A Surgical Oncologist Post-Surgery: Reconstructive Surgery
Many patients, in cases where oncological surgery may have had a disfigurative impact on body aesthetics, may opt for a reconstructive surgery. Reconstruction that follows close to the heels of the oncological surgery is known as ‘Immediate Reconstruction’. Reconstructive Surgery can also be undertaken a few weeks or months later, and is referred to as ‘Delayed Reconstruction’. In such cases, the patient is referred to a plastic surgeon for ‘Oncoplastic Surgery’.
]]>
https://www.senatormedical.se/know-more-about-your-cancer-doctors-who-is-surgical-oncologist-doctor-and-what-he-actually-does/feed/01774Epidemiology of Breast Cancer in Young Women in the Southern part of the Mediterranean Area
https://www.senatormedical.se/breast-cancer-in-sub-mediterranean-territories/
https://www.senatormedical.se/breast-cancer-in-sub-mediterranean-territories/#respondMon, 05 Aug 2019 12:56:42 +0000https://www.senatormedical.se/?p=1873
Breast Cancer Article-June 2017
Abstract: In Northern Africa, the high incidence of breast cancer among young women has been recognized as a particular epidemiologic feature within the region. However, a comprehensive epidemiological overview of the existing data is lacking.
Within this present review we aim to: (i) asses the available and reliable epidemiologic data reported from institutional series and registries (ii) investigate the possible impact of demographic or genetic factors on epidemiology and (iii) describe the distinct risk factors and tumour biology of breast cancer in young women presenting in this region of the world.
The evolution of young breast cancer incidence around the Mediterranean area and particularly in the region of Northern Africa will be discussed, as well as it is association to the existing demographic context. The issue of possible bias likely to influence the reported incidence rates, as obtained from the regional registries, will be elucidated. We will finally underline that interpretation of data coming from these registries should be cautious, as the concentration of resources within some metropolitan centres (or regions) may induce bias in terms of patients’ reporting.
Keywords: Breast cancer, Young women, Cancer registry, Epidemiology, Mediterranean area.
]]>https://www.senatormedical.se/breast-cancer-in-sub-mediterranean-territories/feed/01873What is “Surgical Oncology”?
https://www.senatormedical.se/what-is-surgical-oncology/
https://www.senatormedical.se/what-is-surgical-oncology/#respondWed, 05 Jun 2019 12:13:27 +0000https://www.senatormedical.se/?p=1762Surgical oncology is the medical specialty that is concerned
with the surgical treatment and removal of tumors. In fact, surgery is one of
the oldest means of treating cancer. Ancient Egyptians in the 7th century meticulously described techniques for the removal
of tumors of the breasts. Thanks to recent advances in terms of the safety and
efficacy of anesthesia, surgery, in general, has been rapidly evolving.
The specialists responsible for carrying out these procedures
are called surgical oncologists and are typically general surgeons who
underwent additional training in the management of oncological patients. Thus,
they do not commence their training until after approximately 5 – 7 years of
training in general surgery.
Surgical
oncologists often form part of a multi-disciplinary team and provide valuable
insight to this group of professionals. Surgical oncologists may share their
expertise with regard to the techniques necessary for biopsies, the
resectability of the cancers and the role of surgery, if it is necessary.
They may
subspecialize in varying body regions, to limit their focus to particular types
of cancers. This approach allows for optimal management with regards to the
diagnosis and treatment as well as the prevention of those cancers.
There is often
collaboration with geneticists, pathologists, radiologists and medical
oncologists. Geneticists are vital for giving insights into the screening
strategies and/ or prevention of hereditary cancers. Like other members of the
multi-disciplinary team, they also optimize the treatment possibilities.
Collaboration with pathologists is necessary for ensuring the quality assurance of the surgery and the need for additional therapies based on mutational and/ or tumor immuno-phenotyping. Radiologists and medical oncologists assist with the planning of the surgery and ensure that applicable therapies are used when they are indicated.
Techniques
Surgical oncologists not only remove cancerous
lesions, but some of the surrounding tissue at the site of the lesions as well.
This is a preventative means against local recurrence of the tumor. It is known
as a clear margin incision. In some instances, however, it is not possible to
completely remove the tumor.
Therefore, parts of it are removed in order to
alleviate the symptoms that the mass effect of the tumor produces. This
technique is referred to as debulking. Symptoms of mass effect include pain, bleeding,
obstruction of the airway, or nerve disturbances due to compression.
It is crucial that the surgical oncologist is
skilled in removal of the tumor for quality assurance. This is particularly
important, because adjuvant radio- and chemotherapy may not compensate for
surgeries that have been inadequately or poorly conducted.
Moreover, the draining lymph nodes of the
tissue involved may also be surgically removed. This depends on the type of
cancer and its spread. In cases where there is spreading of the cancer, chemo-
and/ or radiotherapy is necessary. Lymph node involvement may not be a
favorable prognostic sign as this may be an indication that the cancer has had
the chance to metastasize.